U.S, MARIJUANA BUSINESS DAILY (20 June 21) Recreational marijuana makes the most headlines, but a large number of cannabis consumers buy and use the plant for medical and wellness reasons.
These include acute medical conditions such as cancer, chronic pain and epilepsy, as well...
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
CANADA, November 25, 2019 (BOTANIQMAG) According to Statistics Canada, there are 811,000 Canadians taking recreational or illegal cannabis products for their health without a doctor’s note or prescription.
“These are not products that have been approved by Health Canada as over-the-counter medicines (OTCs) or natural health products (NHPs),” notes a...
U.S, January 29, 2020 (ANALYTICALCANNABIS) Several recent studies have suggested that CBD has an antipsychotic effect in people with existing forms of psychosis. But just how the cannabis compound is achieving this effect has remained unclear. Now, researchers from King’s College London say they may know the answer....
U.S, January 20, 2020 (GREENENTREPRENEUR) CBD and THC are the most visible cannabinoids in the wellness and skincare industries today, but with more than 100 known cannabinoids, others are muscling in.
Fueled by growing consumer interest, technological innovation and an ever-expanding body of scientific...
U.S, February 12, 2020 (CANNABISTECH) Solving bioavailability issues with cannabinoids, nanoemulsion technology and ultrasonic techniques increase product effectiveness.
Cannabis has always had an issue with bioavailability. Whether smoked, eaten, or applied, each method of delivery loses a significant percentage of medicinal or...